After months of volatility, investment trusts in the biotech and commodity sectors were the winners in July in both price and NAV terms, according to latest figures.
In its monthly investment companies round-up, trust analysts QuotedData revealed biotech and commodity investment trusts - which have had a difficult time over the last few months in light of the upcoming...
The outperformance of emerging markets that began in January 2016 and extended through the rest of that year and 2017 has continued in the first months of 2018. Perhaps the most important driver behind this sustained strength - the first consecutive years...
Threat of trade war escalating
Following investor ‘criticism’
A question of selectivity
'Impress on senior management the importance of diversity’